SEC Form 4 · accession 0001179110-17-015257
Tabula Rasa HealthCare, Inc. · TRHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Eric R Arnson
10% Owner
Period of report
Dec 8, 2017
Accepted (ET)
Dec 12, 2017 · 4:57 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001651561
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F5 | Dec 8, 2017 | S | 523,805 | $25.85 | D | 1,390,273 | I | By: Originate Growth Fund #1Q, L.P. |
| Common StockF2,F5 | Dec 11, 2017 | S | 160,375 | $25.85 | D | 1,229,898 | I | By: Originate Growth Fund #1Q, L.P. |
| Common StockF3,F5 | Dec 8, 2017 | S | 237,195 | $25.85 | D | 629,594 | I | By: Originate Growth Fund #1A, L.P. |
| Common StockF4,F5 | Dec 11, 2017 | S | 72,625 | $25.85 | D | 556,969 | I | By: Originate Growth Fund #1A, L.P. |
| Common StockF6 | holding | — | — | — | 7,500 | I | By Wife |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares of the Company's common stock sold by Originate Growth Fund #1Q, L.P. in an underwritten public offering completed on December 8, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share.
- F2Represents shares of the Company's common stock sold by Originate Growth Fund #1Q, L.P. upon the exercise of the underwriters' over-allotment option in an underwritten public offering completed on December 11, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share.
- F3Represents shares of the Company's common stock sold by Originate Growth Fund #1A, L.P. in an underwritten public offering completed on December 8, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share.
- F4Represents shares of the Company's common stock sold by Originate Growth Fund #1A, L.P. upon the exercise of the underwriters' over-allotment option in an underwritten public offering completed on December 11, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share.
- F5The general partner of Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P. is Originate Growth GP, LLC. The members of Originate Growth GP, LLC are Glen R. Bressner, Eric R. Arnson and Michael J. Gausling. The members of Originate Growth GP, LLC share voting and dispositive power over the shares held by Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P. Mr. Arnson disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest.
- F6Represents shares held by Mr. Arnson's wife. Mr. Arnson disclaims beneficial ownership of such shares. In addition, 5,565 shares granted to Mr. Bressner in September 2016 and 2,596 shares granted to Mr. Bressner in June 2017 are beneficially owned by Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P., with the shares allocated to each fund on a pro rata basis.